🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementNausea incidence by dose tier — my results so far Page 11

Nausea incidence by dose tier — my results so far

MikeFit_NJ Mon, Jul 22, 2024 at 7:15 AM 52 replies 2,374 viewsPage 11 of 11
nick_newbie
New Member
18
56
Jun 2026
Virginia
Online
Nov 25, 2024 at 4:41 AM#51
MikeFit_NJ said:
Holding the step for six weeks instead of four did it.

Bookmarking. The distinction being drawn above is the one nobody else makes. Sending this to two other people who asked me the same thing last week.

Last edited: Nov 25, 2024 at 7:41 AM
22 20robert_kc, dan_philly, MeganSA_TX and 19 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Nov 28, 2024 at 10:29 PM#52

From the other side of the consultation, briefly. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

23 21NurseKim_ATL, paul_denver, TinaHashiRN and 20 others
Reply Quote Save Share Report
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Dec 2, 2024 at 4:15 PM#53

Old thread, but it comes up first when you search for this, so it is worth updating. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

That is the short version; the long version is somebody else's post.

24 22carlos_SATX, sophie_paris, mel_PDX and 21 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Dec 6, 2024 at 9:59 AM#54
SarahChen_PharmD said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Adding the part of the answer the thread has not reached. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Last edited: Dec 6, 2024 at 12:59 PM
25 23wanda_boise, NurseAsh_DET, BenResearch_OR and 22 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Dec 10, 2024 at 3:41 AM#55

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Dec 10, 2024 at 4:41 AM
26 24KristenIndy, MarkLI_maint, Dr.PeteFamMed and 23 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register